Sign in
4

Changes in Ownership

Mosaic ImmunoEngineering Inc. Filed Acc 0001683168-20-004324

Options or other derivatives

  • EVP, Chief Financial Officer acquired 80,164 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

LYTLE PAUL J · EVP, Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-16 Grant or award : show line 1 in the form Restricted Stock Units +42,392 $3.30 $139,894 42,392 D
2020-12-16 Grant or award : show line 2 in the form Restricted Stock Units +37,772 $3.30 $124,648 80,164 D
Loading xslF345X03/ownership.xml…